Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug
Capdeville, Renaud, Buchdunger, Elisabeth, Zimmermann, Juerg, Matter, Alex
Published in Nature reviews. Drug discovery (01.07.2002)
Published in Nature reviews. Drug discovery (01.07.2002)
Get full text
Journal Article
Imatinib: a selective tyrosine kinase inhibitor
Manley, P.W., Cowan-Jacob, S.W., Buchdunger, E., Fabbro, D., Fendrich, G., Furet, P., Meyer, T., Zimmermann, J.
Published in European journal of cancer (1990) (01.09.2002)
Published in European journal of cancer (1990) (01.09.2002)
Get full text
Journal Article
Intracranial inhibition of platelet-derived growth factor-mediated glioblastoma cell growth by an orally active kinase inhibitor of the 2-phenylaminopyrimidine class
KILIC, Turker, ALBERTA, John A, ZDUNEK, Pawel R, ACAR, Melih, IANNARELLI, Palma, O'REILLY, Terence, BUCHDUNGER, Elisabeth, BLACK, Peter M, STILES, Charles D
Published in Cancer research (Chicago, Ill.) (15.09.2000)
Get full text
Published in Cancer research (Chicago, Ill.) (15.09.2000)
Journal Article
Selective Inhibition of the Platelet-Derived Growth Factor Signal Transduction Pathway by a Protein-Tyrosine Kinase Inhibitor of the 2- Phenylaminopyrimidine Class
Buchdunger, Elisabeth, Zimmermann, Jurg, Mett, Helmut, Meyer, Thomas, Muller, Marcel, Regenass, Urs, Lydon, Nicholas B.
Published in Proceedings of the National Academy of Sciences - PNAS (28.03.1995)
Published in Proceedings of the National Academy of Sciences - PNAS (28.03.1995)
Get full text
Journal Article
Patupilone (epothilone B, ep0906) and imatinib (STI571, Glivec) in combination display enhanced antitumour activity in vivo against experimental rat C6 glioma
O'REILLY, T, WARTMANN, M, MAIRA, S.-M, HATTENBERGER, M, VAXELAIRE, J, MULLER, M, FERRETTI, S, BUCHDUNGER, E, ALTMANN, K.-H, MCSHEEHY, P. M. J
Published in Cancer chemotherapy and pharmacology (01.04.2005)
Published in Cancer chemotherapy and pharmacology (01.04.2005)
Get full text
Journal Article
Preclinical evaluation of the antiproliferative potential of STI571 in Hodgkin's disease
RE, D, WICKENHAUSER, C, AHMADI, T, BUCHDUNGER, E, KOCHANEK, M, DIEHL, V, WOLF, J
Published in British journal of cancer (22.04.2002)
Published in British journal of cancer (22.04.2002)
Get full text
Journal Article
4,5-Dianilinophthalimide: A Protein-Tyrosine Kinase Inhibitor with Selectivity for the Epidermal Growth Factor Receptor Signal Transduction Pathway and Potent in vivo Antitumor Activity
Buchdunger, Elisabeth, Trinks, Uwe, Mett, Helmut, Regenass, Urs, Muller, Marcel, Meyer, Thomas, McGlynn, Elaine, Pinna, Lorenzo A., Traxler, Peter, Lydon, Nicholas B.
Published in Proceedings of the National Academy of Sciences - PNAS (15.03.1994)
Published in Proceedings of the National Academy of Sciences - PNAS (15.03.1994)
Get full text
Journal Article
Pharmacology of imatinib (STI571)
Buchdunger, Elisabeth, O'Reilley, Terence, Wood, Jeanette
Published in European journal of cancer (1990) (01.09.2002)
Published in European journal of cancer (1990) (01.09.2002)
Get full text
Journal Article
Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1 -induced B-lymphoblastic leukemia but not chronic myeloid leukemia
Li, Shaoguang, Hu, Yiguo, Liu, Yuhua, Pelletier, Shawn, Buchdunger, Elisabeth, Warmuth, Markus, Fabbro, Doriano, Hallek, Michael, Van Etten, Richard A
Published in Nature genetics (01.05.2004)
Published in Nature genetics (01.05.2004)
Get full text
Journal Article
Inhibition of obliterative bronchiolitis by platelet-derived growth factor receptor protein-tyrosine kinase inhibitor
Kallio, E, Koskinen, P, Buchdunger, E, Lemström, K
Published in Transplantation proceedings (01.02.1999)
Published in Transplantation proceedings (01.02.1999)
Get full text
Journal Article
Conference Proceeding
PDGF receptor inhibition prevents cardiac allograft arteriosclerosis in cholesterol-fed rabbits
Lemström, K., Sihvola, R., Tikkanen, J., Aaltola, E., Buchdunger, E., Laitinen, O., Koskinen, P.
Published in Transplantation proceedings (01.02.2001)
Published in Transplantation proceedings (01.02.2001)
Get full text
Journal Article
Conference Proceeding
4,5-bis(4-fluoroanilino)phthalimide: A selective inhibitor of the epidermal growth factor receptor signal transduction pathway with potent in vivo antitumor activity
BUCHDUNGER, E, METT, H, LYDON, N. B, TRINKS, U, REGENASS, U, MÜLLER, M, MEYER, T, BEILSTEIN, P, WIRZ, B, SCHNEIDER, P, TRAXLER, P
Published in Clinical cancer research (01.08.1995)
Get full text
Published in Clinical cancer research (01.08.1995)
Journal Article
Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors
Elisabeth Buchdunger, Catherine L. Cioffi, Norman Law, David Stover, Sayuri Ohno-Jones, Brian J. Druker, Nicholas B. Lydon
Published in The Journal of pharmacology and experimental therapeutics (01.10.2000)
Get full text
Published in The Journal of pharmacology and experimental therapeutics (01.10.2000)
Journal Article
Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia
Druker, Brian J, Talpaz, Moshe, Resta, Debra J, Peng, Bin, Buchdunger, Elisabeth, Ford, John M, Lydon, Nicholas B, Kantarjian, Hagop, Capdeville, Renaud, Ohno-Jones, Sayuri, Sawyers, Charles L
Published in The New England journal of medicine (05.04.2001)
Published in The New England journal of medicine (05.04.2001)
Get full text
Journal Article
Inhibition of PDGF receptor signaling in tumor stroma enhances antitumor effect of chemotherapy
PIETRAS, Kristian, RUBIN, Kristofer, SJÖBLOM, Tobias, BUCHDUNGER, Elisabeth, SJÖQUIST, Mats, HELDIN, Carl-Henrik, ÖSTMAN, Arne
Published in Cancer research (Chicago, Ill.) (01.10.2002)
Get full text
Published in Cancer research (Chicago, Ill.) (01.10.2002)
Journal Article
Imatinib mesylate is a potent inhibitor of the ABCG2 (BCRP) transporter and reverses resistance to topotecan and SN-38 in vitro
HOUGHTON, Peter J, GERMAIN, Glen S, HARWOOD, Franklin C, SCHUETZ, John D, STEWART, Clinton F, BUCHDUNGER, Elisabeth, TRAXLER, Peter
Published in Cancer research (Chicago, Ill.) (01.04.2004)
Published in Cancer research (Chicago, Ill.) (01.04.2004)
Get full text
Journal Article
Inhibition of platelet-derived growth factor receptors reduces interstitial hypertension and increases transcapillary transport in tumors
PIETRAS, Kristian, ÖSTMAN, Arne, SJÖQUIST, Mats, BUCHDUNGER, Elisabeth, REED, Rolf K, HELDIN, Carl-Henrik, RUBIN, Kristofer
Published in Cancer research (Chicago, Ill.) (01.04.2001)
Get full text
Published in Cancer research (Chicago, Ill.) (01.04.2001)
Journal Article
Prevention of cardiac allograft arteriosclerosis by protein-tyrosine kinase inhibitor selective for platelet-derived growth factor receptor
Koskinen, P, Sihvola, R, Myllärniemi, M, Häyry, P, Buchdunger, E, Lemström, K
Published in Transplantation proceedings (01.02.1999)
Published in Transplantation proceedings (01.02.1999)
Get full text
Journal Article
Conference Proceeding
The Insulin-Like Growth Factor-I Receptor Kinase Inhibitor, NVP-ADW742, Sensitizes Small Cell Lung Cancer Cell Lines to the Effects of Chemotherapy
WARSHAMANA-GREENE, G. Sakuntala, LITZ, Julie, BUCHDUNGER, Elisabeth, GARCIA-ECHEVERRIA, Carlos, HOFMANN, Francesco, KRYSTAL, Geoffrey W
Published in Clinical cancer research (15.02.2005)
Published in Clinical cancer research (15.02.2005)
Get full text
Journal Article